Cargando…
Post mastectomy radiotherapy for elderly patients with intermediate risk (T1-2N1 OR T3N0) breast cancer: a systematic review and meta-analysis
BACKGROUND: To determine if PMRT for elderly patients (>65 years old) with intermediate risk breast cancer (T1-2N1, T3N0) improves outcomes. METHODS: We performed a systematic review and meta-analysis to compare the effects of PMRT to no PMRT for elderly patients with intermediate-risk breast can...
Autores principales: | Tseng, Michelle, Vellayappan, Balamurugan, Choong, Rachel, Appalanaido, Gokula Kumar, Soon, Yu Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799025/ https://www.ncbi.nlm.nih.gov/pubmed/35117945 http://dx.doi.org/10.21037/tcr.2019.07.23 |
Ejemplares similares
-
Life-threatening Bleed Secondary to Tumor Shrinkage Effectively Palliated with Radiotherapy
por: Tseng, Michelle, et al.
Publicado: (2017) -
The Benefit of Post-Mastectomy Radiotherapy in ypN0 Patients after Neoadjuvant Chemotherapy According to Molecular Subtypes
por: Cho, Won Kyung, et al.
Publicado: (2019) -
Established and Validated Novel Nomogram for Predicting Prognosis of Post-Mastectomy pN0-1 Breast Cancer without Adjuvant Radiotherapy
por: Qi, Wei-Xiang, et al.
Publicado: (2021) -
Identification of Risk Factors for Locoregional Recurrence in Breast Cancer Patients with Nodal Stage N0 and N1: Who Could Benefit from Post-Mastectomy Radiotherapy?
por: Jwa, Eunjin, et al.
Publicado: (2015) -
Utility of post mastectomy radiotherapy among patients with T1/ T2 N1 disease: A retrospective cohort study
por: Vohra, Lubna M., et al.
Publicado: (2021)